文献速递神经肿瘤

miR-448抑制糖酵解增强胶质瘤放射敏感性

Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity.
PubMed 文献 · J Neurosurg · 2019-04-19

该研究探讨miR-448通过抑制糖酵解增强胶质瘤细胞放射敏感性的机制。研究使用胶质瘤患者组织、GBM细胞系、正常星形胶质细胞及小鼠皮下U87荷瘤模型,采用生物信息学、生化检测、荧光素酶报告基因等方法。结果显示miR-448在胶质瘤组织和GBM细胞系中显著下调,通过负调控HIF-1α信号及其下游糖酵解因子HK1、HK2、LDHA抑制糖酵解,过表达miR-448可增加胶质瘤细胞对X射线的敏感性,体内实验亦验证高表达miR-448通过抑制糖酵解因子增强放射敏感性。结论提示miR-448-HIF-1α轴是克服胶质瘤放疗抵抗的潜在治疗靶点。

要点

  • miR-448在胶质瘤组织和GBM细胞系中显著下调,发挥抑癌因子作用。
  • miR-448通过负调控HIF-1α信号及下游HK1、HK2、LDHA抑制糖酵解。
  • 过表达miR-448可增强胶质瘤细胞和小鼠皮下U87肿瘤的放射敏感性。

核心结论

  • miR-448通过抑制HIF-1α信号进而负调控糖酵解过程,促进胶质瘤放射敏感性。
  • 新发现的miR-448-HIF-1α轴是潜在治疗靶点,可能有助于克服胶质瘤放疗抵抗。

研究设计与样本

  • 使用胶质瘤患者组织样本、GBM细胞系和正常人类星形胶质细胞,以及小鼠皮下U87荷瘤模型。
  • 采用生物信息学分析、生化检测、荧光素酶报告基因实验及小鼠皮下成瘤模型。
  • 检测葡萄糖消耗、LDH活性和细胞ATP以评估胶质瘤细胞糖酵解能力。

主要发现

  • miR-448在胶质瘤患者组织和GBM细胞系中均显著下调。
  • miR-448作为肿瘤抑制因子,通过负调控HIF-1α信号活性及其下游糖酵解调节因子HK1、HK2和LDHA抑制胶质瘤糖酵解。
  • 过表达miR-448增加胶质瘤细胞的X射线敏感性。
  • 小鼠皮下U87荷瘤模型体内实验验证,高表达miR-448通过抑制糖酵解因子增强胶质瘤放射敏感性。

临床怎么用

  • miR-448-HIF-1α轴可作为潜在治疗靶点,用于探索克服胶质瘤放疗抵抗的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although glucose metabolism reengineering is a typical feature of various tumors, including glioma, key regulators of glycolytic reprogramming are still poorly understood. The authors sought to investigate whether glycolysis inhibition by microRNA (miR)-448 increases radiosensitivity in glioma cells. METHODS: The authors used glioma tissue samples from glioma patients, cells from glioblastoma (GBM) cell lines and normal human astrocyte cells, and subcutaneous tumor-bearing U87 cells in mice to examine the effects of signaling regulation by miR-448 in the response of glioma tissues and cells to radiation treatment. Techniques used for investigation included bioinformatics analyses, biochemical assays, luciferase reporter assays, and establishment of subcutaneous tumors in a mouse model. Glucose consumption, LDH activity, and cellular ATP were measured to determine the ability of glioma cells to perform glycolysis. Expression of HIF-1α was measured as a potential target gene of miR-448 in glycolysis. RESULTS: miR-448 was detected and determined to be significantly downregulated in both glioma tissues from glioma patients and GBM cell lines. Furthermore, miR-448 acted as a tumor-inhibiting factor and suppressed glycolysis in glioma by negatively regulating the activity of HIF-1α signaling and then interfering with its downstream regulators relative to glycolysis, HK1, HK2, and LDHA. Interestingly, overexpression of miR-448 increased the x-radiation sensitivity of glioma cells. Finally, in in vivo experiments, subcutaneous tumor-bearing U87 cells in a mouse model verified that high expression of miR-448 also enhanced glioma radiosensitivity via inhibiting glycolytic factors. CONCLUSIONS: miR-448 can promote radiosensitivity by inhibiting HIF-1α signaling and then negatively controlling the glycolysis process in glioma. A newly identified miR-448-HIF-1α axis acts as a potentially valuable therapeutic target that may be useful in overcoming radioresistance in glioma treatment.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lan F, Qin Q, Yu H, et al. Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity. J Neurosurg. 2019. PMID: 31003211. doi:10.3171/2018.12.JNS181798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。